HR 1298 · 111th Congress 2009โ€“2011, ended

Pharmaceutical Market Access and Drug Safety Act of 2009

Latest action · Mar 5, 2009 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 4, 2009
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.

Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.

Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.

Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.

Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.

States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.

Requires the Secretary to educate consumers regarding prescription drug importation.

Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.

Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.

Cosponsors 36

Members who signed on, in the order they did. Signatures ran from Mar 4, 2009 to Sep 16, 2010; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-MOJo Ann EmersonOriginalMar 4, 2009
D-TNBart GordonMar 19, 2009
D-NHCarol Shea-PorterMar 19, 2009
D-MDChris Van HollenMar 19, 2009
D-PAChristopher P. CarneyMar 19, 2009
D-MIDale E. KildeeMar 19, 2009
R-INDan BurtonMar 19, 2009
D-MSGene TaylorMar 19, 2009
D-OHMarcy KapturMar 19, 2009
R-IDMichael K. SimpsonMar 19, 2009
R-VAFrank R. WolfApr 2, 2009
D-ILJanice D. SchakowskyApr 2, 2009
R-WADoc HastingsApr 27, 2009
R-MIPeter HoekstraApr 27, 2009
R-WIThomas E. PetriApr 27, 2009
R-PATodd Russell PlattsApr 27, 2009
D-PAJohn P. MurthaMay 12, 2009
D-NYGary L. AckermanJun 18, 2009
D-NYMichael A. ArcuriJun 18, 2009
R-CATom McClintockJun 18, 2009
D-ORPeter A. DeFazioJul 14, 2009
D-OHBetty SuttonJul 28, 2009
D-CAJane HarmanJul 28, 2009
D-NYTimothy H. BishopJul 28, 2009
R-VABob GoodlatteOct 6, 2009
D-ILJerry F. CostelloOct 6, 2009
D-GAJim MarshallOct 6, 2009
D-MAJohn F. TierneyOct 6, 2009
D-WVNick J. Rahall IIOct 6, 2009
R-MDRoscoe G. BartlettOct 6, 2009
D-AZHarry E. MitchellOct 20, 2009
R-TNJohn J. Duncan, Jr.Oct 20, 2009
D-CALynn C. WoolseyOct 20, 2009
R-TXRon PaulOct 20, 2009
R-OHSteven C. LaTouretteOct 20, 2009
D-WISteve KagenSep 16, 2010

Withdrew 1 Rodney Alexander R-LA Oct 27, 2009

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 4, 2009
Health Subcommittee
Referred Mar 5, 2009

Actions 3

Everything that happened, newest first.

  1. Mar 5, 2009Referred to the Subcommittee on Health.
  2. Mar 4, 2009Introduced in House
  3. Mar 4, 2009Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

About this bill 1

Products that name it in their title: its number, its law number or one of its short titles.

ProductTitleKindPublished
RS22660Prescription Drug Importation: How S. 1232 (S. 525/H.R. 1298) Would Change Current Law ArchivedReportJun 16, 2009

Related bills 4

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 525Pharmaceutical Market Access and Drug Safety Act of 2009Identical billMar 5, 2009
S 1232Pharmaceutical Market Access and Drug Safety Act of 2009Identical billJun 11, 2009
S 1808Control Spending Now ActRelated billOct 20, 2009
S 3415Fair Pricing for Prescription Drugs ActRelated billMay 25, 2010

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
Short Titles as Introduced
Pharmaceutical Market Access and Drug Safety Act of 2009

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 4, 2009Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.